• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup.一项评估0.05%维甲酸痤疮洗剂与粉底彩妆兼容性的半脸对照研究。
J Clin Aesthet Dermatol. 2020 Oct;13(10):E53-E58. Epub 2020 Oct 1.
2
Randomized, Observer-blind, Split-face Compatibility Study with Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% gel and Facial Foundation Makeup.1.2%磷酸克林霉素/3.75%过氧化苯甲酰凝胶与粉底液的随机、观察者盲法、半脸相容性研究
J Clin Aesthet Dermatol. 2015 Sep;8(9):25-32.
3
Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream.制剂对药物耐受性和患者偏好的影响:维 A 酸品牌乳液与仿制药乳膏的比较。
J Drugs Dermatol. 2022 Aug 1;21(8):875-880. doi: 10.36849/JDD.6945.
4
Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.0.05%维甲酸洗剂每日一次治疗中度至重度寻常痤疮:性别和种族对疗效及安全性的影响
J Drugs Dermatol. 2019 Nov 1;18(11):1128-1138.
5
Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.一种新型0.05%维甲酸洗剂每日一次治疗成年女性中度或重度寻常痤疮的疗效和耐受性
J Drugs Dermatol. 2019 Nov 1;18(11):1147-1154.
6
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.新型0.05%维甲酸洗剂用于9岁及以上中重度寻常痤疮的每日一次治疗:疗效与安全性评估
J Drugs Dermatol. 2018 Oct 1;17(10):1084-1091.
7
Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.0.05%维甲酸洗剂用于女性中度和重度寻常痤疮的每日一次治疗:年龄对疗效和耐受性的影响
J Drugs Dermatol. 2019 Dec 1;18(12):1218-1225.
8
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.新型0.05%维甲酸乳液用于亚洲人群中重度寻常痤疮的每日一次治疗
J Drugs Dermatol. 2019 Sep 1;18(9):910-916.
9
Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.新型0.05%维甲酸洗剂用于西班牙裔人群中重度寻常痤疮的每日一次治疗
J Drugs Dermatol. 2019 Jan 1;18(1):32-38.
10
Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.新型0.05%维甲酸洗剂用于成年及青春期女性中重度寻常痤疮的每日一次治疗。
J Drugs Dermatol. 2019 Feb 1;18(2):178-188.

引用本文的文献

1
Effect of Makeup Use on Depressive Symptoms: An Open, Randomized and Controlled Trial.使用化妆品对抑郁症状的影响:一项开放性随机对照试验。
Dermatol Ther (Heidelb). 2024 Mar;14(3):777-791. doi: 10.1007/s13555-024-01128-w. Epub 2024 Mar 21.
2
Acne treatment challenges - Recommendations of Latin American expert consensus.痤疮治疗挑战 - 拉丁美洲专家共识建议。
An Bras Dermatol. 2024 May-Jun;99(3):414-424. doi: 10.1016/j.abd.2023.09.001. Epub 2024 Feb 23.

本文引用的文献

1
Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology.采用聚合乳液技术优化外用固定复方制剂卤倍他索/他扎罗汀乳膏的配方。
J Dermatolog Treat. 2021 Jun;32(4):391-398. doi: 10.1080/09546634.2019.1668907. Epub 2019 Sep 26.
2
Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate.寻常痤疮的局部治疗:疗效、副作用及依从率。
J Int Med Res. 2019 Jul;47(7):2987-2992. doi: 10.1177/0300060519847367. Epub 2019 May 24.
3
Polymeric Emulsion Technology Applied to Tretinoin.应用于维甲酸的聚合物乳液技术
J Drugs Dermatol. 2019 Apr 1;18(4):s148-154.
4
Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.新型 0.05%维 A 酸乳膏治疗中重度寻常痤疮:亚组安全性和耐受性评估。
J Dermatolog Treat. 2020 Mar;31(2):160-167. doi: 10.1080/09546634.2019.1587884. Epub 2019 Apr 2.
5
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.新型0.05%维甲酸洗剂用于9岁及以上中重度寻常痤疮的每日一次治疗:疗效与安全性评估
J Drugs Dermatol. 2018 Oct 1;17(10):1084-1091.
6
Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers.耻辱感可预测痤疮患者的健康相关生活质量受损、心理困扰和躯体症状。
PLoS One. 2018 Sep 28;13(9):e0205009. doi: 10.1371/journal.pone.0205009. eCollection 2018.
7
How Acne Bumps Cause the Blues: The Influence of Acne Vulgaris on Self-Esteem.痤疮如何导致情绪低落:寻常痤疮对自尊的影响。
Int J Womens Dermatol. 2017 Dec 6;4(1):12-17. doi: 10.1016/j.ijwd.2017.10.004. eCollection 2018 Mar.
8
A review of diagnosis and treatment of acne in adult female patients.成年女性患者痤疮的诊断与治疗综述
Int J Womens Dermatol. 2017 Dec 23;4(2):56-71. doi: 10.1016/j.ijwd.2017.10.006. eCollection 2018 Jun.
9
Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients.成人痤疮与青少年痤疮:1167例患者的回顾性研究
J Clin Aesthet Dermatol. 2018 Jan;11(1):21-25. Epub 2018 Jan 1.
10
Why Topical Retinoids Are Mainstay of Therapy for Acne.为什么外用维甲酸类药物是痤疮治疗的主要手段。
Dermatol Ther (Heidelb). 2017 Sep;7(3):293-304. doi: 10.1007/s13555-017-0185-2. Epub 2017 Jun 5.

一项评估0.05%维甲酸痤疮洗剂与粉底彩妆兼容性的半脸对照研究。

A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup.

作者信息

Bhatia Neal, Kircik Leon H, Shamban Ava, Bhatt Varsha, Pillai Radhakrishnan, Guenin Eric

机构信息

Dr. Bhatia is with Therapeutics Clinical Research in San Diego, California.

Dr. Kircik is with Indiana University School of Medicine in Indianapolis, IN, Physicians Skin Care, PLLC, in Louisville, Kentucky, and Icahn School of Medicine at Mount Sinai in New York, New York.

出版信息

J Clin Aesthet Dermatol. 2020 Oct;13(10):E53-E58. Epub 2020 Oct 1.

PMID:33584959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7840090/
Abstract

This study was conducted to assess compatibility of tretinoin 0.05% acne lotion with foundation makeup. This was a single-center, evaluator-blinded, randomized, controlled clinical trial. Participants were randomized to apply tretinoin 0.05% lotion to either the right or left side of the face before applying full-face foundation makeup. Participants were enrolled at a single center in the United States. Female individuals aged 18 to 50 years who used facial foundation makeup ≥5 days per week were included. Investigator-assessed grading for foundation coverage and participant evaluations of makeup appearance were conducted at post-makeup application (Post-Makeup) and Hour 6 (6H) timepoints. Antera 3D® images were taken for skin texture roughness analysis and tolerability evaluations were performed at baseline, post-tretinoin application, Post-Makeup, and 6H timepoints. A total of 30 participants were enrolled and 29 completed the study. There were no significant differences between tretinoin treated and untreated sides for any outcomes of investigator-assessed grading of foundation (percentage coverage, blotchiness, overall coverage, skin tone evenness, visual smoothness). There was a small but statistically significant worsening in percent coverage at 6H versus Post-Makeup on the untreated side, but not the treated side. As rated by participants, even/full coverage and skin smoothness were significantly better on the tretinoin-lotion treated versus the untreated side. Three-dimensional imaging showed there were no significant differences in skin roughness between the treated and untreated sides. Participants reported overall satisfaction with the tretinoin lotion-treated side. Tretinoin 0.05% lotion did not interfere with facial makeup application or wearability and was well tolerated.

摘要

本研究旨在评估0.05%维甲酸痤疮洗剂与粉底的兼容性。这是一项单中心、评估者盲法、随机对照临床试验。参与者被随机分为两组,在全脸涂抹粉底前,分别在面部右侧或左侧涂抹0.